Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purified Inactivated Japanese Encephalitis Vaccine in Infants
NCT04223037Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2015
- Primary completion
- Mar 2018
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Japanese encephalitis vaccine in Japanese encephalitis (JE) (3 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoints: Local and systemic adverse reactions at 6 months and Immunogenecity detected by plaque reduction neutralization test at 1 month. Status: unknown.
02
Drugs
Japanese encephalitis vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT04223037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04223037.